Mathur Roli, Swaminathan Soumya
Scientist E and Head, ICMR Bioethics Unit, National Centre for Disease Informatics and Research, Indian Council of Medical Research, Bengaluru, 562 110, India.,
Former Director General, Indian Council of Medical Research, and Secretary Department of Health Research, and Deputy Director General of Programmes, World Health Organization, Geneva, SWITZERLAND.,
Indian J Med Ethics. 2018 Jul-Sep;3(3):201-204. doi: 10.20529/IJME.2018.065.
The Indian Council of Medical Research (ICMR) has been at the forefront in setting up the ethical guidance for the conduct of biomedical and health research in India. The latest version of National Guidelines for Biomedical and Health Research Involving Human Participants, 2017 was planned in order to provide a more detailed guidance to the existing topics in view of emerging ethical concerns and to add a number of newer areas in which guidance was lacking. The scope of the guidelines has been expanded to include socio-behavioural research related to health and research involving biological material and datasets. The guidelines have 12 sections which cover a wide range of topics and areas of research. The first six sections are more generic, applying to all types of biomedical and health research, while the next six sections are more subject specific. The guidelines have been revised in consultation with a large number of experts and stakeholders and went through an exhaustive process stretching over a period of two years in its drafting, review, consultation and finalisation. This commentary seeks to explain the process and key components of the Guidelines.
印度医学研究理事会(ICMR)在为印度生物医学和健康研究的开展制定伦理指导方针方面一直处于前沿。计划出台2017年版《涉及人类受试者的生物医学和健康研究国家指导方针》的最新版本,以便鉴于新出现的伦理问题,对现有主题提供更详细的指导,并增加一些缺乏指导的新领域。指导方针的范围已扩大到包括与健康相关的社会行为研究以及涉及生物材料和数据集的研究。该指导方针有12个章节,涵盖广泛的主题和研究领域。前六个章节更具通用性,适用于所有类型的生物医学和健康研究,而后六个章节则更具主题针对性。该指导方针已在与大量专家和利益相关者协商的基础上进行了修订,在起草、审查、咨询和定稿过程中历经了长达两年的详尽过程。本评论旨在解释该指导方针的制定过程和关键组成部分。